home / stock / rna / rna news


RNA News and Press, Avidity Biosciences Inc. From 11/18/25

Stock Information

Company Name: Avidity Biosciences Inc.
Stock Symbol: RNA
Market: NASDAQ
Website: aviditybiosciences.com

Menu

RNA RNA Quote RNA Short RNA News RNA Articles RNA Message Board
Get RNA Alerts

News, Short Squeeze, Breakout and More Instantly...

RNA - Health Care shines as November sell off continues; See 10 stand out stocks

2025-11-18 11:25:00 ET More on markets UBS shrugs off high valuations as it focuses on strong earnings Cantor Fitzgerald says current de-risking clears a runway for a year-end rally 2 Events Could Make Me Buy More Than Ever Commodities And The Next Major Macr...

RNA - October Marks Busiest Month For $10 Billion-Plus M&A Deals Worldwide Since 2022

2025-11-18 06:24:00 ET Eight M&A deals with transaction values greater than $10 billion were announced in October, marking the busiest month for large M&A deals worldwide since May 2022. ... Read the full article on Seeking Alpha For further details see: Octo...

RNA - iShares Biotechnology ETF: The M&A Wave Behind The Suddenly Booming Biotech Sector

2025-11-17 09:44:20 ET Biotech has been on a nice recent run in recent months, as can be seen in the chart of the iShares Biotechnology ETF ( IBB ) . The sector has been a significant laggard compared to the overall market for many, many years now.... Read the full article...

RNA - Momentum movers: 10 stocks surging over 40% over the last month

2025-11-12 13:12:41 ET More on markets Growth or Value? Why not both, here are 10 names to watch AI boom vs. Dot-Com bust: TD Wealth says today’s market has real profits, not just promises Bulls vs. Bears: What's ahead for NVDA as earnings data looms D...

RNA - Avidity Biosciences GAAP EPS of -$1.27 misses by $0.16, revenue of $12.48M

2025-11-10 16:54:06 ET More on Avidity Biosciences Novartis' Deal For Avidity And Its Late-Stage Muscle Disease Assets Has Caveats Novartis' Avidity Deal: Growth Accretive, Multiple Gated By Execution Avidity Biosciences: Maintaining 'Strong Buy' Rating Based On Acce...

RNA - Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights PR Newswire Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion ; Avidity expects to separate its early-stage precision cardiology programs into a...

RNA - Halper Sadeh LLC Encourages WTRG, PLYM, RNA Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages WTRG, PLYM, RNA Shareholders to Contact the Firm to Discuss Their Rights PR Newswire Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Halper Sa...

RNA - Expected US Company Earnings on Thursday, November 6th, 2025

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

RNA - Janus Henderson Global Life Sciences Fund Q3 2025 Portfolio Update

2025-11-06 00:30:00 ET The following segment was excerpted from Janus Henderson Global Life Sciences Fund Q3 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Janus Henderson Global Life Sciences Fund Q3 2025 Portfolio Update

RNA - Key deals this week: Qorvo, Chewy, Sotherly Hotels, Novartis, CSG Systems, and more

2025-11-01 15:15:34 ET More on M&A tickers, etc. DocGo: Revenue Collapse Overshadows Acquisition, Is Cheap But Still A Hold Blackstone Q3: Distributable Earnings Up +48% (Rating Upgrade) Old Republic International Corporation (ORI) Q3 2025 Earnings Call Transcrip...

Previous 10 Next 10